Explore comprehensive CDMO services offered by BioCina, supporting end-to-end Anlaytical Testing, Clinical Studies, Drug Development, Manufacturing and Packaging. BioCina enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Australia
Description: BioCina is a global, end-to-end contract development and manufacturing organization (CDMO) that specializes in the development and commercial manufacturing of microbial-based biological pharmaceuticals, including proteins, plasmid DNA, and mRNA. With facilities in Adelaide and Perth, Australia, BioCina offers services from pre-clinical to commercial stages, supported by state-of-the-art facilities, expertise in regulatory compliance, and a strong record of inspections by agencies like the US FDA and EMA. The company's focus is solely on manufacturing for its clients.
